QOL Medical, LLC /
Evoke Pharma, Inc.
QOL Medical, LLC agrees to buy Evoke Pharma, Inc.
Source for the buyer and target: Evoke Pharma Inc
For the buyer and target.
“As previously disclosed, Evoke Pharma, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), with QOL Medical, LLC (“Parent”) and Parent’s wholly owned subsidiary, QOL-EOS Merger Sub, Inc. (“Merger Sub”), on November 3, 2025.”
Published 17 Dec 2025
Open the sourceWhat happened
QOL Medical, LLC agreed to acquire Evoke Pharma, Inc. for $11.00 in cash per Company Share, according to a filing dated Dec. 17, 2025. [01]
Who is involved, and the source
Everything on this page comes from the source below, quoted word for word.
Advisers
Target
- Financial adviser to the targetStifelSource: SEC filing, as of 17 Nov 2025
Each adviser in its source's own words. An adviser's own announcement is labelled as one: it is not independent reporting. Advisers are not parties to the deal.
QOL Medical, LLC agrees to buy Evoke Pharma, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“QOL Medical, LLC agrees to buy Evoke Pharma, Inc. QOL Medical, LLC agreed to acquire Evoke Pharma, Inc. for $11.00 in cash per Company Share, according to a filing dated Dec. 17, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly